ID

24968

Description

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Lien

https://clinicaltrials.gov/ct2/show/NCT00291876

Mots-clés

Versions (2)
  1. 22/08/2017 22/08/2017 -
  2. 23/08/2017 23/08/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

23 août 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

Anglais

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 Formulaires  
Study administration
Description

Study administration

Center
Description

Center

Type de données

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Description

Date of Visit

Type de données

date

Alias
UMLS CUI [1]
C1320303
Subject Number
Description

Subject Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
MEDICATION
Description

MEDICATION

Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
Description

pharmaceutical preparations

Type de données

integer

Alias
UMLS CUI [1]
C0013227
MEDICATION
Description

MEDICATION

Trade / Generic Name
Description

pharmaceutical preparations

Type de données

text

Alias
UMLS CUI [1]
C0013227
Medical Indication
Description

drug Indication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0199176
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
Total daily dose
Description

total daily dose

Type de données

text

Alias
UMLS CUI [1]
C2348070
Route
Description

administration route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Start Date
Description

Medication Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C1521826
UMLS CUI [1,2]
C0808070
End Date
Description

Medication End Date

Type de données

date

Alias
UMLS CUI [1,1]
C1521826
UMLS CUI [1,2]
C0806020
Medication Ongoing: check box if continuing at end of Visit 24
Description

Medication Ongoing

Type de données

boolean

Alias
UMLS CUI [1]
C2826666
Retour au début de la page

Similar models

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
MEDICATION
Item
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
integer
C0013227 (UMLS CUI [1])
pharmaceutical preparations
Code List
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
CL Item
No (1)
CL Item
Yes, please complete the following table. (2)
Item Group
MEDICATION
pharmaceutical preparations
Item
Trade / Generic Name
text
C0013227 (UMLS CUI [1])
drug Indication
Item
Medical Indication
boolean
C0199176 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
total daily dose
Item
Total daily dose
text
C2348070 (UMLS CUI [1])
Item
Route
text
C0013153 (UMLS CUI [1])
administration route
Code List
Route
CL Item
External (EXT)
CL Item
Intradermal (ID)
CL Item
Inhalation (IH)
CL Item
Intramuscular (IM)
CL Item
Intraarticular (IR)
CL Item
Intrathecal (IT)
CL Item
Intravenous (IV)
CL Item
Intranasal (NA)
CL Item
Other (OTH)
CL Item
Parenteral (PE)
CL Item
Oral (PO)
CL Item
Rectal (PR)
CL Item
Subcutaneous (SC)
CL Item
Sublingual (SL)
CL Item
Transdermal (TD)
CL Item
Topical (TO)
CL Item
Unknown (UNK)
CL Item
Vaginal (VA)
Medication Start Date
Item
Start Date
date
C1521826 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Medication End Date
Item
End Date
date
C1521826 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Medication Ongoing
Item
Medication Ongoing: check box if continuing at end of Visit 24
boolean
C2826666 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial